Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration

BackgroundThe in vivo kinetics of nanoparticles is an essential to understand the hazard of nanoparticles. Here, the absorption, distribution, and excretion patterns of titanium dioxide (TiO2) and zinc oxide (ZnO) nanoparticles following oral administration were evaluated.MethodsNanoparticles were orally administered to rats for 13 weeks (7 days/week). Samples of blood, tissues (liver, kidneys, spleen, and brain), urine, and feces were obtained at necropsy. The level of Ti or Zn in each sample was measured using inductively coupled plasma-mass spectrometry.ResultsTiO2 nanoparticles had extremely low absorption, while ZnO nanoparticles had higher absorption and a clear dose-response curve. Tissue distribution data showed that TiO2 nanoparticles were not significantly increased in sampled organs, even in the group receiving the highest dose (1041.5 mg/kg body weight). In contrast, Zn concentrations in the liver and kidney were significantly increased compared with the vehicle control. ZnO nanoparticles in the spleen and brain were minimally increased. Ti concentrations were not significantly increased in the urine, while Zn levels were significantly increased in the urine, again with a clear dose-response curve. Very high concentrations of Ti were detected in the feces, while much less Zn was detected in the feces.ConclusionsCompared with TiO2 nanoparticles, ZnO nanoparticles demonstrated higher absorption and more extensive organ distribution when administered orally. The higher absorption of ZnO than TiO2 nanoparticles might be due to the higher dissolution rate in acidic gastric fluid, although more thorough studies are needed.

[1]  Jürgen Lademann,et al.  Skin penetration and cellular uptake of amorphous silica nanoparticles with variable size, surface functionalization, and colloidal stability. , 2012, ACS nano.

[2]  Bong Hyun Chung,et al.  Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. , 2009, Toxicology and applied pharmacology.

[3]  Wu De-chang,et al.  Age-dependent variation of zinc-65 metabolism in LACA mice. , 1991 .

[4]  Yiwei Teow,et al.  Health Impact and Safety of Engineered Nanomaterials , 2011 .

[5]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[6]  Yuan Ge,et al.  Identification of Soil Bacteria Susceptible to TiO2 and ZnO Nanoparticles , 2012, Applied and Environmental Microbiology.

[7]  Jin Hong,et al.  Size-dependent tissue kinetics of PEG-coated gold nanoparticles. , 2010, Toxicology and applied pharmacology.

[8]  Yiwei Teow,et al.  Health impact and safety of engineered nanomaterials. , 2011, Chemical communications.

[9]  W. Kreyling,et al.  Differences in the biokinetics of inhaled nano- versus micrometer-sized particles. , 2013, Accounts of chemical research.

[10]  Kianoush Khosravi-Darani,et al.  The Applications of Nanotechnology in Food Industry , 2011, Critical reviews in food science and nutrition.

[11]  T. Larsen,et al.  Transfer of dietary zinc and fat to milk--evaluation of milk fat quality, milk fat precursors, and mastitis indicators. , 2008, Journal of dairy science.

[12]  Alexander T Florence,et al.  Nanoparticle uptake by the oral route: Fulfilling its potential? , 2005, Drug discovery today. Technologies.

[13]  Hans C. Fischer,et al.  Pharmacokinetics of Nanoscale Quantum Dots: In Vivo Distribution, Sequestration, and Clearance in the Rat , 2006 .

[14]  Hak Soo Choi,et al.  Rapid translocation of nanoparticles from the lung airspaces to the body , 2010, Nature Biotechnology.

[15]  X. Yan,et al.  Age-dependent variation of zinc-65 metabolism in LACA mice. , 1991, International journal of radiation biology.

[16]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[17]  Manuela Semmler-Behnke,et al.  Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration , 2011, Nanotoxicology.

[18]  Mara Ghiazza,et al.  Physico-chemical features of engineered nanoparticles relevant to their toxicity , 2010, Nanotoxicology.

[19]  T. Akasaka,et al.  In vivo internal diffusion of several inorganic microparticles through oral administration. , 2009, Bio-medical materials and engineering.

[20]  Z. Chai,et al.  Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. , 2007, Toxicology letters.

[21]  R M Albrecht,et al.  Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. , 2001, Journal of pharmaceutical sciences.

[22]  Ai Lin Chun,et al.  Will the public swallow nanofood? , 2009, Nature nanotechnology.

[23]  A. Florence,et al.  Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency , 1990, The Journal of pharmacy and pharmacology.

[24]  Ande Bao,et al.  Dynamic Imaging of Functionalized Multi‐Walled Carbon Nanotube Systemic Circulation and Urinary Excretion , 2008 .

[25]  Craig A. Poland,et al.  Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal oxide nanoparticles. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[26]  W. MacNee,et al.  Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes , 2011, Particle and Fibre Toxicology.

[27]  Seung‐Min Paek,et al.  Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles , 2012, International Journal of Nanomedicine.

[28]  Ming-Hsien Tsai,et al.  Persistent Tissue Kinetics and Redistribution of Nanoparticles, Quantum Dot 705, in Mice: ICP-MS Quantitative Assessment , 2007, Environmental health perspectives.

[29]  D. Wurster,et al.  Phenobarbital Adsorption from Simulated Intestinal Fluid, U.S.P., and Simulated Gastric Fluid, U.S.P., by Two Activated Charcoals , 1988, Pharmaceutical Research.

[30]  G W Halbert,et al.  The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats , 1989, The Journal of pharmacy and pharmacology.

[31]  Vicki Stone,et al.  An in vitro liver model - assessing oxidative stress and genotoxicity following exposure of hepatocytes to a panel of engineered nanomaterials , 2012, Particle and Fibre Toxicology.

[32]  G. Hill,et al.  Effects of dietary zinc and iron supplementation on mineral excretion, body composition, and mineral status of nursery pigs. , 2005, Journal of animal science.

[33]  Michael J. Derelanko,et al.  Handbook of Toxicology , 2001 .

[34]  P. Biswas,et al.  Concept of Assessing Nanoparticle Hazards Considering Nanoparticle Dosemetric and Chemical/Biological Response Metrics , 2010, Journal of toxicology and environmental health. Part A.

[35]  Dong Wook Kim,et al.  Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure , 2012, International journal of nanomedicine.

[36]  E. Dopp,et al.  Titanium dioxide nanoparticles induce oxidative stress and DNA-adduct formation but not DNA-breakage in human lung cells , 2009, Particle and Fibre Toxicology.